Viking Therapeutics Balance Sheet (2014-2026) | VKTX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	8.83M	11.26M	26.37M	178.60M	16.23M	29.41M	36.63M	18.36M	69.52M	37.19M	55.52M	195.58M	43.91M	50.35M	26.68M	37.94M	33.88M	100.38M	165.81M	118.12M
Prepaid Assets (Quarter)	1.15M	0.92M	0.62M	0.39M	1.09M	0.96M	3.41M	3.93M	0.96M	0.67M	2.52M	0.64M	0.14M	1.73M	1.13M	0.86M	2.81M	2.24M	1.81M	1.22M
Current Assets (Quarter)	237.66M	224.28M	210.53M	193.30M	179.86M	165.15M	167.04M	149.47M	399.37M	381.30M	367.23M	966.34M	945.72M	936.65M	907.22M	866.02M	827.02M	738.70M	715.60M	608.21M
Non-Current Assets
Other Non-Current Assets (Quarter)			0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.03M
Non-Current Assets (Quarter)	0.18M	0.19M	0.13M	1.73M	1.65M	1.54M	1.49M	1.43M	1.32M	1.36M	1.26M	1.18M	1.11M	1.24M	1.10M	0.97M	0.83M	0.71M	0.13M	0.03M
Assets (Quarter)	237.84M	224.47M	210.66M	195.03M	181.51M	166.68M	168.53M	150.90M	400.69M	382.66M	368.49M	967.52M	946.84M	937.89M	908.32M	866.99M	827.85M	739.41M	715.73M	608.24M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	4.21M	2.85M	1.44M	3.12M	6.10M	3.14M	8.53M	3.80M	5.61M	5.71M	7.51M	5.22M	11.09M	0.25M	9.81M	7.70M	5.49M	4.41M	53.25M	67.18M
Notes Payables (Quarter)
Payables (Quarter)	4.21M	2.85M	1.44M	3.12M	6.10M	3.14M	8.53M	3.80M	5.61M	5.71M	7.51M	5.22M	11.09M	0.25M	9.81M	7.70M	5.49M	4.41M	53.25M	67.18M
Accumulated Expenses (Quarter)
Other Accumulated Expenses (Quarter)	8.46M	8.39M	7.30M	8.00M	8.52M	10.62M	13.11M	11.54M	7.55M	7.38M	11.30M	27.22M	13.67M	24.95M	17.11M	11.37M	26.02M	21.22M	23.28M	39.14M
Current Leases (Quarter)	0.20M	0.12M	0.03M	0.15M	0.24M	0.30M	0.30M	0.31M	0.31M	0.32M	0.32M	0.33M	0.33M	0.48M	0.49M	0.50M	0.47M	0.44M	0.14M
Total Current Liabilities (Quarter)	12.87M	11.35M	8.78M	11.27M	14.86M	14.06M	21.95M	15.65M	13.48M	13.40M	19.14M	32.77M	25.09M	25.68M	27.41M	19.57M	31.98M	26.07M	76.67M	106.33M
Non-Current Liabilities
Convertible Debt (Quarter)
Non-Current Deffered Revenue (Quarter)
Operating Leases (Quarter)				1.49M	1.41M	1.34M	1.26M	1.18M	1.10M	1.02M	0.94M	0.85M	0.77M	0.76M	0.63M	0.50M	0.41M	0.32M
Other Non-Current Liabilities (Quarter)
Total Non-Current Liabilities (Quarter)				1.49M	1.41M	1.34M	1.26M	1.18M	1.10M	1.02M	0.94M	0.85M	0.77M	0.76M	0.63M	0.50M	0.41M	0.32M
Total Liabilities (Quarter)	12.87M	11.35M	8.78M	12.76M	16.28M	15.40M	23.21M	16.83M	14.58M	14.42M	20.07M	33.63M	25.86M	26.44M	28.04M	20.07M	32.39M	26.39M	76.67M	106.33M
Shareholder's Equity
Common Equity (Quarter)	224.97M	213.12M	201.88M	182.27M	165.23M	151.28M	145.32M	134.06M	386.12M	368.24M	348.42M	933.89M	920.98M	911.45M	880.28M	846.92M	795.46M	713.03M	639.06M	501.92M
Shareholder's Equity (Quarter)	224.97M	213.12M	201.88M	182.27M	165.23M	151.28M	145.32M	134.06M	386.12M	368.24M	348.42M	933.89M	920.98M	911.45M	880.28M	846.92M	795.46M	713.03M	639.06M	501.92M
Liabilities and Shareholders Equity (Quarter)	237.84M	224.47M	210.66M	195.03M	181.51M	166.68M	168.53M	150.90M	400.69M	382.66M	368.49M	967.52M	946.84M	937.89M	908.32M	866.99M	827.85M	739.41M	715.73M	608.24M
Treasury Shares (Quarter)	1.05M	0.96M	1.03M	1.46M	2.19M	2.19M	0.18M	2.19M	2.19M	0.18M	0.18M	2.83M	2.83M				2.30M	2.22M	2.11M	0.03M
Retained Earnings (Quarter)	-197.58M	-210.83M	-223.18M	-239.28M	-256.72M	-272.49M	-292.05M	-311.58M	-330.81M	-353.34M	-377.94M	-405.30M	-427.55M	-452.49M	-487.91M	-533.54M	-599.10M	-689.88M	-847.55M	-1005.87M
Shares Outstanding (Quarter)	78.19M	78.23M	78.25M	77.37M	76.69M	76.69M	78.26M	79.32M	100.03M	100.03M	100.11M	110.23M	110.80M	111.43M	111.57M	112.29M	112.33M	112.45M	114.79M	115.89M

Research Tools

Viking Therapeutics Balance Sheet (2014-2026) | VKTX

Create an account

Sign In

Reset Password